NAN
NANOSONICS LIMITED ORDINARYNanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
NAN
NAN
NANOSONICS LIMITED ORDINARY
Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 6.93% | — |
| 10 July | 6.93% | — |
| 9 July | 6.95% | — |
| 8 July | 6.94% | — |
| 7 July | 6.92% | — |
| 6 July | 6.95% | — |
| 3 July | 6.90% | — |
| 2 July | 6.90% | — |
| 1 July | 6.95% | — |
Nanosonics Limited (NAN) Short Interest Summary
Nanosonics Limited (NAN) currently has 6.93% of its shares sold short (20.7 million shares, worth approximately $67.7 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes NAN the #43 most shorted stock on the ASX most shorted list. Short interest in NAN is down 0.02% over the past week and down 0.63% over the past month. NAN is part of the Health Care sector on the ASX.
Recent NAN Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 6.93% | 20.7M | $3.23 |
| 10 July 2026 | 6.93% | 20.7M | $3.24 |
| 9 July 2026 | 6.95% | 20.8M | $3.35 |
| 8 July 2026 | 6.94% | 20.7M | $3.30 |
| 7 July 2026 | 6.92% | 20.7M | $3.37 |
| 6 July 2026 | 6.95% | 20.8M | $3.43 |
| 3 July 2026 | 6.90% | 20.6M | $3.35 |
| 2 July 2026 | 6.90% | 20.6M | $3.27 |
| 1 July 2026 | 6.95% | 20.8M | $3.26 |
| 30 June 2026 | 7.00% | 20.9M | $3.33 |
NAN Short Selling — Frequently Asked Questions
What is Nanosonics Limited (NAN)'s current short interest?
Nanosonics Limited (NAN) currently has a short interest of 6.93% of total shares outstanding. This means 6.93% of NAN's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is NAN heavily shorted on the ASX?
NAN has a moderate level of short interest at 6.93%. While below the heavily shorted threshold of 10%, this indicates notable bearish positioning. NAN is currently ranked #43 among the most shorted stocks on the ASX.
What does short interest mean for NAN investors?
Short interest in NAN shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 6.93%, NAN's short interest is at a moderate level. See our short squeeze candidates and days to cover analysis for more context.
Where does this NAN short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for NAN.